1. CSIG-11. TARGETING PD-L1 IN GLIOBLASTOMA USING NANOPARTICLE-BASED GENE EDITING. (9th November 2020) Authors: Tran, An; Fierro, Javier; Dou, Huanyu Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IMMU-15. ALLOGENIC MACROPHAGES IMMUNOTHERAPY IN A MOUSE MODEL OF GLIOBLASTOMA. (23rd April 2019) Authors: Zhang, Zijian Zhang; Bastian, Anthony Bastian; Hong, Daewoo; Espinal, Jamil; Orji, Cara; Lee, Soyoon; Dou, Huanyu Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMMU-37. DISRUPTION OF PD-L1 BY ENHANCED TWO-SGRNAS CRISPR/CAS9 IN TREATMENT OF GLIOBLASTOMA. (12th November 2021) Authors: Fierro, Javier; Perez, joshua; Aguilar, Rocio; Dipasquale, Jake; Tran, An; Factoriza, Chris; Dou, Huanyu Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immune Modulation by Volatile Anesthetics. (August 2016) Authors: Stollings, Lindsay M.; Jia, Li-Jie; Tang, Pei; Dou, Huanyu; Lu, Binfeng; Xu, Yan Journal: Anesthesiology Issue: Volume 125:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte––macrophage drug delivery. (December 2009) Authors: Nowacek, Ari S; Miller, Reagan L; McMillan, JoEllyn; Kanmogne, Georgette; Kanmogne, Michel; Mosley, R Lee; Ma, Zhiya; Graham, Sabine; Chaubal, Mahesh; Werling, Jane; Rabinow, Barrett; Dou, Huanyu; Gendelman, Howard E Journal: Nanomedicine Issue: Volume 4:Number 8(2009) Page Start: 903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte––macrophage drug delivery. (December 2009) Authors: Nowacek, Ari S; Miller, Reagan L; McMillan, JoEllyn; Kanmogne, Georgette; Kanmogne, Michel; Mosley, R Lee; Ma, Zhiya; Graham, Sabine; Chaubal, Mahesh; Werling, Jane; Rabinow, Barrett; Dou, Huanyu; Gendelman, Howard E Journal: Nanomedicine Issue: Volume 4:Number 8(2009) Page Start: 903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NGMA-2. Dual sgRNA-directed PD-L1 knockout in human glioblastoma cells using the CRISPR/Cas9 system. (5th July 2021) Authors: Fierro, Javier; Dipasquale, Jake; Aguilar, Rocio; Perez, Joshua; Tran, An; Factoriza, Chris; Dou, Huanyu Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 2 Page Start: ii4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OMRT-12. Nanoparticle-based CRISPR-Cas9 delivery for anti-glioblastoma immunotherapy. (5th July 2021) Authors: Aguilar, Rocio; Fierro, Javier; Perez, Joshua; Dou, Huanyu Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 2 Page Start: ii9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OTME-18. Targeted CRISPR/Cas9 gene-editing regulates the brain tumor environment. (5th July 2021) Authors: Perez, Joshua; Fierro, Javier; Aguilar, Rocio; Dou, Huanyu Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 2 Page Start: ii17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TAMI-14. NANOPARTICLE DELIVERY OF PD-L1 CRISPR/CAS9 PLASMID DNA FOR ANTI-GLIOBLASTOMA IMMUNOTHERAPY. (9th November 2020) Authors: Fierro, Javier; Tran, An; Factoriza, Chris; Chin, Brandon; Dou, Huanyu Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗